Oral cavity malignancy, excluding non-melanoma skin cancer, is the most common carcinoma of the head and neck. 90% of these neoplasms are squamous cell carcinoma (SCCA), with minor salivary gland malignancies and other rare tumors comprising the rest.[1][2] The tongue, along with the lip and the floor of the mouth, represents one of the most commonly involved subsites within the oral cavity.[1 ...
Increasing incidence and improving survival of oral tongue squamous
Enhanced radiation sensitivity in HPV-positive head and neck cancer. Cancer research 73, 4791-4800 (2013). Article CAS Google Scholar Lv, J.-W. et al. A national study of survival trends and ...
Global research trends in tongue cancer from 2000 to 2022 ...
Objectives This study conducts a systematic bibliometric analysis of tongue cancer publications to identify key topics, hotspots, and research distribution. Methods We analyzed tongue cancer publications in the Web of Science core collection database, assessing their quantity and quality. We investigated contributors, including countries, affiliations, journals, authors, and categories, within ...
Frontiers
Forty-six patients had a second primary tumor, of whom two were ≤40 years old. Regarding OS, elderly 5-year survival was 62% compared to 73% among younger patients, while elderly 10-year survival was 51%, and 70% in younger patients (log rank test p = 0.0006, Figure 1 ).
Prognostic impact of lymphovascular and perineural invasion in ...
The incidence rates of PNI in tongue cancer and buccal mucosa carcinoma were approximately 28.3% and 16%, respectively, and this may be attributed to the rich nerve distribution in the tongue 16.
Current trends and themes of oral cancer research: A bibliometric
Authors with landmark articles on oral cancer statistics, OPMD, and HPV and oro-pharyngeal cancer remained the highest cited. This may be due to the fact that these articles were published earlier and had a longer citation window. Additionally, being landmark articles in the field, they were likely to be cited by research articles on similar ...
Imaging-based T stage (iT) as a predictive and prognostic... : Cancer
Advanced oral tongue carcinomas spread differently from buccal mucosa cancers, and an independent imaging-based T4 staging system can help clinicians decide their management approach. However, extensive research is required to assess the role of these imaging-based biomarkers and their impact on patient survival. Financial support and ...
Full article: Radiation therapy's efficacy on tongue cancer: a
Tongue cancer accounts for 30%-50% of oral cancers. The frontal two-thirds of the tongue (with the circumvallate papilla as the boundary) is where the tongue can move. ... This was a retrospective study with several research data limitations. To improve the therapeutic effects of tongue cancer, a combined treatment consisting of surgery ...
Prediction of Prognosis of Tongue Squamous Cell Carcinoma Based on
The role of radiomics in tongue cancer: A new tool for prognosis prediction. Head Neck. 2023;45(4):849-861. Crossref. PubMed. Google Scholar. 30. ... This article was published in Technology in Cancer Research & Treatment. VIEW ALL JOURNAL METRICS. Article usage * Total views and downloads: 0 * Article usage tracking started in December 2016.
Mechanisms correlated with chemotherapy resistance in tongue
Tongue cancer is one of the most common and deadly types of head and neck cancer. The incidence of tongue cancer has been particularly high and remained been increasing in some countries. A main reason for poor prognosis and clinical outcome for tongue cancer was its resistance to chemotherapies, behind which the mechanisms have been not clear.
Speech disorders in patients with Tongue squamous cell carcinoma: A
Speech disorders are common dysfunctions in patients with tongue squamous cell carcinoma (TSCC) that can diminish their quality of life. There are few studies with multidimensional and longitudinal assessments of speech function in TSCC patients. This longitudinal observational study was conducted at the Hospital of Stomatology, Sun Yat-sen University, China, from January 2018 to March 2021.
Oral cancer
Oral cancer articles from across Nature Portfolio. Oral cancer is a cancerous growth in the mouth, on the tongue, lips or gums. The most common type of oral cancer is squamous cell carcinoma. Oral ...
In-depth metaproteomics analysis of tongue coating for gastric cancer
Study design and clinical characteristics. A total of 417 tongue-coating samples from 180 individuals with gastric cancer and 185 individuals without gastric cancer from five independent research centers were collected in this study (Fig. 1A). Fifty-seven samples of five individuals from the ZUGC-Lab (Key Laboratory of Prevention, Diagnosis, and Therapy of Upper Gastrointestinal Cancer of ...
Prognostic biomarkers for oral tongue squamous cell carcinoma: a
Existing review articles for prognostic biomarkers of tongue cancer (Ferrari et al, 2009; Bello et al, ... Research Group of Cancer Research and Translational Medicine, Medical Faculty, University ...
Tongue cancer: Symptoms, pictures, and outlook
This article looks at tongue cancer in more detail, including pictures, symptoms, stages, causes, and more. ... which can lead to cancer growth. However, a lot of research is still necessary to ...
Study: Mouth Bacterium Found in 50% of Colorectal Cancer Tumors
New research found that a specific subtype of a bacterium commonly found in the mouth and linked to gum disease was also present in 50% of colorectal cancer tumors that were studied by researchers.
Researchers Discover Cell 'Crosstalk' That Triggers Cancer Cachexia
New research from the University of Oklahoma reveals a previously unknown chain of events sparking the development of cancer cachexia, a debilitating muscle-wasting condition that almost always occurs in people diagnosed with pancreatic cancer. The research, led by Min Li, Ph.D., a professor in the OU College of Medicine, is published in the journal Cancer Cell.
Study links accelerated aging to cancer risk in younger adults
Related article As colorectal cancer rises among younger adults, some seek colonoscopies earlier "We all know cancer is an aging disease. However, it is really coming to a younger population.
Many Cancer Drugs Still Unproven 5 Years After Accelerated Approval
MONDAY, April 8, 2024 (HealthDay News) -- New research questions the effectiveness of the U.S. Food and Drug Administration's accelerated drug approval program after finding that many cancer drugs ...
Mouth cancer: the challenges ahead
'Mouth Cancer Action Month 2020 United Kingdom Survey', Atomik Research, September 2020, sample 2,006. Oral Health Foundation (2021). 'Mouth Cancer Action Month 2021: Nationwide Survey'.
Moderna jumps as vaccine shows benefit in head and neck cancer in early
Moderna shares rose 8% to a three-month high on Tuesday after the company's individualized cancer vaccine developed with Merck showed positive response in an early-stage trial in patients with a ...
Study: Many cancer drugs unproven 5 years after accelerated approval
FILE - A sign for the Food and Drug Administration is displayed outside their offices in Silver Spring, Md., on Dec. 10, 2020. According to research published Sunday, April 7, 2024, in the Journal of the American Medical Association, most cancer drugs granted accelerated approval by the FDA, meant to give patients early access to promising drugs, do not demonstrate such benefits within five years.
UC experts present at national neurology conference
Collaborative University of Cincinnati Cancer Center team opens Phase 2 brain tumor trial March 26, 2024. A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas, the most deadly form of brain tumors.
Impact analysis of oral cancer staging during COVID-19
The methodology of the study involved a retrospective analysis comparing oral cancer diagnoses from 26 March 2019 to 25 March 2020 (pre-pandemic; control group) with those from 26 March 2020 to 25 ...
COMMENTS
Oral cavity malignancy, excluding non-melanoma skin cancer, is the most common carcinoma of the head and neck. 90% of these neoplasms are squamous cell carcinoma (SCCA), with minor salivary gland malignancies and other rare tumors comprising the rest.[1][2] The tongue, along with the lip and the floor of the mouth, represents one of the most commonly involved subsites within the oral cavity.[1 ...
Enhanced radiation sensitivity in HPV-positive head and neck cancer. Cancer research 73, 4791-4800 (2013). Article CAS Google Scholar Lv, J.-W. et al. A national study of survival trends and ...
Objectives This study conducts a systematic bibliometric analysis of tongue cancer publications to identify key topics, hotspots, and research distribution. Methods We analyzed tongue cancer publications in the Web of Science core collection database, assessing their quantity and quality. We investigated contributors, including countries, affiliations, journals, authors, and categories, within ...
Forty-six patients had a second primary tumor, of whom two were ≤40 years old. Regarding OS, elderly 5-year survival was 62% compared to 73% among younger patients, while elderly 10-year survival was 51%, and 70% in younger patients (log rank test p = 0.0006, Figure 1 ).
The incidence rates of PNI in tongue cancer and buccal mucosa carcinoma were approximately 28.3% and 16%, respectively, and this may be attributed to the rich nerve distribution in the tongue 16.
Authors with landmark articles on oral cancer statistics, OPMD, and HPV and oro-pharyngeal cancer remained the highest cited. This may be due to the fact that these articles were published earlier and had a longer citation window. Additionally, being landmark articles in the field, they were likely to be cited by research articles on similar ...
Advanced oral tongue carcinomas spread differently from buccal mucosa cancers, and an independent imaging-based T4 staging system can help clinicians decide their management approach. However, extensive research is required to assess the role of these imaging-based biomarkers and their impact on patient survival. Financial support and ...
Tongue cancer accounts for 30%-50% of oral cancers. The frontal two-thirds of the tongue (with the circumvallate papilla as the boundary) is where the tongue can move. ... This was a retrospective study with several research data limitations. To improve the therapeutic effects of tongue cancer, a combined treatment consisting of surgery ...
The role of radiomics in tongue cancer: A new tool for prognosis prediction. Head Neck. 2023;45(4):849-861. Crossref. PubMed. Google Scholar. 30. ... This article was published in Technology in Cancer Research & Treatment. VIEW ALL JOURNAL METRICS. Article usage * Total views and downloads: 0 * Article usage tracking started in December 2016.
Tongue cancer is one of the most common and deadly types of head and neck cancer. The incidence of tongue cancer has been particularly high and remained been increasing in some countries. A main reason for poor prognosis and clinical outcome for tongue cancer was its resistance to chemotherapies, behind which the mechanisms have been not clear.
Speech disorders are common dysfunctions in patients with tongue squamous cell carcinoma (TSCC) that can diminish their quality of life. There are few studies with multidimensional and longitudinal assessments of speech function in TSCC patients. This longitudinal observational study was conducted at the Hospital of Stomatology, Sun Yat-sen University, China, from January 2018 to March 2021.
Oral cancer articles from across Nature Portfolio. Oral cancer is a cancerous growth in the mouth, on the tongue, lips or gums. The most common type of oral cancer is squamous cell carcinoma. Oral ...
Study design and clinical characteristics. A total of 417 tongue-coating samples from 180 individuals with gastric cancer and 185 individuals without gastric cancer from five independent research centers were collected in this study (Fig. 1A). Fifty-seven samples of five individuals from the ZUGC-Lab (Key Laboratory of Prevention, Diagnosis, and Therapy of Upper Gastrointestinal Cancer of ...
Existing review articles for prognostic biomarkers of tongue cancer (Ferrari et al, 2009; Bello et al, ... Research Group of Cancer Research and Translational Medicine, Medical Faculty, University ...
This article looks at tongue cancer in more detail, including pictures, symptoms, stages, causes, and more. ... which can lead to cancer growth. However, a lot of research is still necessary to ...
New research found that a specific subtype of a bacterium commonly found in the mouth and linked to gum disease was also present in 50% of colorectal cancer tumors that were studied by researchers.
New research from the University of Oklahoma reveals a previously unknown chain of events sparking the development of cancer cachexia, a debilitating muscle-wasting condition that almost always occurs in people diagnosed with pancreatic cancer. The research, led by Min Li, Ph.D., a professor in the OU College of Medicine, is published in the journal Cancer Cell.
Related article As colorectal cancer rises among younger adults, some seek colonoscopies earlier "We all know cancer is an aging disease. However, it is really coming to a younger population.
MONDAY, April 8, 2024 (HealthDay News) -- New research questions the effectiveness of the U.S. Food and Drug Administration's accelerated drug approval program after finding that many cancer drugs ...
'Mouth Cancer Action Month 2020 United Kingdom Survey', Atomik Research, September 2020, sample 2,006. Oral Health Foundation (2021). 'Mouth Cancer Action Month 2021: Nationwide Survey'.
Moderna shares rose 8% to a three-month high on Tuesday after the company's individualized cancer vaccine developed with Merck showed positive response in an early-stage trial in patients with a ...
FILE - A sign for the Food and Drug Administration is displayed outside their offices in Silver Spring, Md., on Dec. 10, 2020. According to research published Sunday, April 7, 2024, in the Journal of the American Medical Association, most cancer drugs granted accelerated approval by the FDA, meant to give patients early access to promising drugs, do not demonstrate such benefits within five years.
Collaborative University of Cincinnati Cancer Center team opens Phase 2 brain tumor trial March 26, 2024. A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas, the most deadly form of brain tumors.
The methodology of the study involved a retrospective analysis comparing oral cancer diagnoses from 26 March 2019 to 25 March 2020 (pre-pandemic; control group) with those from 26 March 2020 to 25 ...